Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile.
Targeted post-exposure prophylaxis represents a more efficient use of the stockpile than treatment alone.
McCaw
James M
JM
Vaccine and Immunisation Research Group, Melbourne School of Population Health, University of Melbourne and Murdoch Childrens Research Institute, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Wood
James G
JG
McBryde
Emma S
ES
Nolan
Terry M
TM
Wu
Joseph T
JT
Lipsitch
Marc
M
McVernon
Jodie
J
D000998:Antiviral Agents / Q000627:therapeutic use*; D001315:Australia / Q000453:epidemiology; D004196:Disease Outbreaks / Q000517:prevention & control*; D024882:Drug Resistance, Viral; D006291:Health Policy; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D009439:Neuraminidase / Q000037:antagonists & inhibitors
D000998:Antiviral Agents; D009439:Neuraminidase